Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Defining the 10 Year Risk of Disease Progression in Stage A0 CLL.

Anne Gardiner, BSc, Zadie Davis, MSc, Parker Anton, BSc, Giles Best, PhD, Rachel Ibbotson, PhD, Sarah Mould, BSc, Sharron Glide, BSc, Peter Thomas, PhD, Jenny Orchard, MD, David Graham Oscier, MD

Blood (2006) 108 (11): 2772.

https://doi.org/10.1182/blood.V108.11.2772.2772

Published: 2006

Journal Articles

Prognostic Factors in the UK LRF CLL4 Trial.

David Graham Oscier, MD, Rachel Wade, MSc, Jenny Orchard, MD, Zadie Davis, MSc, Giles Best, PhD, Alison Morilla, BSc, Vasantha Brito-Bapapulle, PhD, Estella Matutes, MD, Sue Richards, DPhil, Daniel Catovsky, MD

Blood (2006) 108 (11): 299.

https://doi.org/10.1182/blood.V108.11.299.299

Published: 2006

Journal Articles

Prognostic Factors in the UK LRF CLL4 Trial.

David Graham Oscier, MD, Sue Richards, DPhil, Jenny Orchard, MD, Zadie Davis, MSc, Giles Best, PhD, Alison Morilla, BSc, Vasantha Brito-Bapapulle, PhD, Estella Matutes, MD, Andrew Pettitt, MD, Daniel Catovsky, MD

Blood (2005) 106 (11): 2099.

https://doi.org/10.1182/blood.V106.11.2099.2099

Published: 2005

Journal Articles

Zap70 Methylation Correlates with Zap70 Expression in Chronic Lymphocytic Leukemia.

David Graham Oscier, MD, Anton Parker, BSc, Zadie Davis, MSc, Wirtz Michaela, MSc, Schmitz Oliver, PhD, Jenny Orchard, MD, Martin Corcoran, PhD

Blood (2004) 104 (11): 962.

https://doi.org/10.1182/blood.V104.11.962.962

Published: 2004

Journal Articles

A subset of t(11;14) lymphoma with mantle cell features displays mutated IgV H genes and includes patients with good prognosis, nonnodal disease

Jenny Orchard, Richard Garand, Zadie Davis, Gavin Babbage, Surinder Sahota, Estella Matutes, Daniel Catovsky, Peter W. Thomas, Hervé Avet-Loiseau, David Oscier

Blood (2003) 101 (12): 4975–4981.

https://doi.org/10.1182/blood-2002-06-1864

Published: 2003

Journal Articles

Features of the overexpressed V1-69 genes in the unmutated subset of chronic lymphocytic leukemia are distinct from those in the healthy elderly repertoire

Kathleen N. Potter, Jenny Orchard, Eustacia Critchley, C. Ian Mockridge, Annette Jose, Freda K. Stevenson

Blood (2003) 101 (8): 3082–3084.

https://doi.org/10.1182/blood-2002-08-2432

Published: 2003

NARROW

Defining the 10 Year Risk of Disease Progression in Stage A0 CLL.

Prognostic Factors in the UK LRF CLL4 Trial.

Prognostic Factors in the UK LRF CLL4 Trial.

Zap70 Methylation Correlates with Zap70 Expression in Chronic Lymphocytic Leukemia.

A subset of t(11;14) lymphoma with mantle cell features displays mutated IgV H genes and includes patients with good prognosis, nonnodal disease

Features of the overexpressed V1-69 genes in the unmutated subset of chronic lymphocytic leukemia are distinct from those in the healthy elderly repertoire

Email alerts

ASH Publications

American Society of Hematology

Defining the 10 Year Risk of Disease Progression in Stage A0 CLL.

Prognostic Factors in the UK LRF CLL4 Trial.

Prognostic Factors in the UK LRF CLL4 Trial.

Zap70 Methylation Correlates with Zap70 Expression in Chronic Lymphocytic Leukemia.

A subset of t(11;14) lymphoma with mantle cell features displays mutated IgV H genes and includes patients with good prognosis, nonnodal disease

Features of the overexpressed V1-69 genes in the unmutated subset of chronic lymphocytic leukemia are distinct from those in the healthy elderly repertoire

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only